Abstract
SummaryDuring the past few decades, major advances have been achieved in the treatment of early breast cancer (BC) resulting in improvements of inavasive disease free survival and overall survival. New treatment substances have been established in neoadjuvant and adjuvant settings. On the other hand, deescalation strategies are studied to get more tailored treatment concepts.
Funder
Medical University of Graz
Publisher
Springer Science and Business Media LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献